A Proteomic Method for Analysis of CYP450s Protein Expression Changes in Carbon Tetrachloride Induced Male Rat Liver Microsomes
Overview
Affiliations
Carbon tetrachloride (CCl(4)) is a well-known model compound for producing chemical hepatic injury. Cytochrome P450 is an important monooxygenase in biology. We investigated the CYP450 protein expression in the in vivo hepatotoxicity of rats induced by CCl(4). In this experiment, CCl(4) were administered to male rats, and their livers at 24h post-dosing were applied to the proteomic analysis. Blood biochemistry and histopathology were examined to identify specific changes. At the same time, a novel acetylation stable isotopic labeling method coupled with LTQ-FTICR mass spectrometry was applied to disclose the changes of cytochrome P450 expression amounts. The quantitative proteomics method demonstrated its correlation coefficient was 0.9998 in a 100-fold dynamic range and the average ratio of the labeled peptides was 1.04, which was very close to the theoretical ratio of 1.00 and the standard deviation (S.D.) of 0.21. With this approach, 17 cytochrome P450 proteins were identified and quantified with high confidence. Among them, the expression amount of 2C11, 3A2, and 2 E1 were down-regulated, while that of 2C6, 2B2, and 2B1 were up-regulated.
Wu R, Xiao Z, Zhang X, Liu F, Zhou W, Zhang Y Front Pharmacol. 2018; 9:229.
PMID: 29593545 PMC: 5861220. DOI: 10.3389/fphar.2018.00229.
Citrate functionalized MnO in nanotherapy of hepatic fibrosis by oral administration.
Adhikari A, Polley N, Darbar S, Bagchi D, Kumar Pal S Future Sci OA. 2017; 2(4):FSO146.
PMID: 28116129 PMC: 5242211. DOI: 10.4155/fsoa-2016-0029.
Quantitative proteome analysis of colorectal cancer-related differential proteins.
Zhang Y, Liu Y, Ye Y, Shen D, Zhang H, Huang H J Cancer Res Clin Oncol. 2016; 143(2):233-241.
PMID: 27659785 DOI: 10.1007/s00432-016-2274-5.
Chen S, Zou L, Li L, Wu T PLoS One. 2013; 8(1):e53662.
PMID: 23341968 PMC: 3544925. DOI: 10.1371/journal.pone.0053662.
Serum proteomic profiling in patients with drug-induced liver injury.
Bell L, Vuppalanchi R, Watkins P, Bonkovsky H, Serrano J, Fontana R Aliment Pharmacol Ther. 2012; 35(5):600-12.
PMID: 22403816 PMC: 3654532. DOI: 10.1111/j.1365-2036.2011.04982.x.